Stada Reveals Skin-Care Ambitions With Acquisition Of GSK Brands
Stada has snapped up a basket of OTC skin-care brands from GSK, with CEO Peter Goldschmidt telling HBW Insight that the category is a "key focus" for the Germany-based firm.
You may also be interested in...
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.
In the wake of its joint venture with Pfizer, GSK Consumer Healthcare has shaken up how it reports its sales by category to highlight the "main drivers" of performance.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.